Ticker Symbol: AMRN
Amarin Corp - ADR
$4.11 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Ireland
Currency:
USD
Asset
Type: ADR
CIK:0000897448
Company Profile
amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. vascepa® (icosapent ethyl) is amarin's first fda approved product and is available in the united states by prescription. for more information about vascepa visit www.vascepa.com.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: http://www.amarincorp.com/
CEO: John Thero
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.75
Change:
$0.01
(
2.35%)
Days Range: $0.72 - $0.78
Beta: 1.75
52wk. High: $2.23
52wk. Low: $0.70
Ytd. Change -35.27%
50 Day Moving Average: $0.89
200 Day Moving Average: $1.13
Shares Outstanding: 98801982
Valuation
Market Cap: 7.5B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A